SEONGNAM, South Korea, Feb. 25, 2025 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed ...
Children aged 1 to 15 years within the Panvel Municipal Corporation (PMC) limits will receive the Japanese Encephalitis ...
Taking a significant step toward public health protection, the Pimpri-Chinchwad Municipal Corporation (PCMC) will roll out a ...
Authorities confirm a second human case of Japanese encephalitis in a person from northern Victoria, likely exposed in the ...
WHO declares encephalitis a global health emergency. Learn about its symptoms, risks, and strategies for prevention and ...
A Sydney man has died from Japanese encephalitis (JE), the first death from the mosquito-borne disease in NSW in close to ...
SK bioscience's development of vaccine for Japanese encephalitis could not only help to protect against Japanese Encephalitis but also pave the way to the development of an mRNA technology that ...
in 2022 to support preclinical and early clinical trials of Japanese encephalitis as well as Lassa fever virus vaccines. A further USD 100 million in funding could be made available later to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results